Journal profile · PERIPHERAL VASCULAR DISEASE
Journal of the American Society of Hypertension
ISSN 1933-1711 · Elsevier Ireland Ltd · UNITED STATES · Bimonthly · Founded 2007
Journal of the American Society of Hypertension: subscription journal; review 6–12 weeks (community reports); community-reported acceptance: fairly easy; 0 articles in 2025.
Scope
Aims, scope and focus
Journal of the American Society of Hypertension is published by Elsevier Ireland Ltd. By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Cardiovascular Health and Disease Prevention and Renin-Angiotensin System Studies, together about 55.6% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Cessation. The Journal of the American Society of Hypertension (JASH) publishes peer-reviewed articles on the topics of basic, applied and translational research on blood pressure, hypertension and related cardiovascular disorders and factors; as well as clinical research and clinical trials in hypertension. Original research studies, reviews, hypotheses, editorial commentary and special reports spanning the spectrum of human and experimental animal and tissue research will be considered. All research studies must have been conducted following animal welfare guidelines. Studies involving human subjects or tissues must have received approval of the appropriate institutional committee charged with oversight of human studies and informed consent must be obtained.
Source: LetPub
Research area (LetPub): PERIPHERAL VASCULAR DISEASE
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine34.1%
- Cardiovascular Health and Disease PreventionMedicine14.7%
- Renin-Angiotensin System StudiesMedicine6.9%
- Sodium Intake and HealthNursing6.7%
- Cardiovascular Function and Risk FactorsMedicine5.2%
- Hormonal Regulation and HypertensionMedicine3.2%
- Chronic Kidney Disease and DiabetesMedicine2.8%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | Q1 | 75/324 | 77th |
| Internal Medicine | Q2 | 36/128 | 72nd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4.8LetPub ·
- SJR 2026-06
- 0.9LetPub ·
- SNIP 2026-06
- 1.05LetPub ·
- h-index
- 42LetPub ·
- h-index
- 74OpenAlex ·
- i10-index
- 625OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 98LetPub ·
Articles by year OpenAlex count · 2,199 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 883 |
| 2025 | 0 | 0 | 1,421 |
| 2024 | 0 | 0 | 1,693 |
| 2023 | 0 | 0 | 2,006 |
| 2022 | 0 | 0 | 2,293 |
| 2021 | 0 | 0 | 2,605 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Ireland Ltd
- Country or region
- UNITED STATES
- Frequency
- Bimonthly
- Founded
- 2007
- ISSN
- 1933-1711
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of the American Society of Hypertension
How long does peer review take at Journal of the American Society of Hypertension?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is Journal of the American Society of Hypertension open access, and what is the APC?
Journal of the American Society of Hypertension is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .